Malcolm Hoenlein's most recent trade in Fortress Biotech Inc was a trade of 49,383 Common Stock, par value $0.001 done . Disclosure was reported to the exchange on Jan. 1, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Fortress Biotech Inc | Malcolm Hoenlein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2025 | 49,383 | 88,425 (0%) | 0% | 0 | Common Stock, par value $0.001 | |
Fortress Biotech Inc | Malcolm Hoenlein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2024 | 3,333 | 39,042 (0%) | 0% | 0 | COMMON STOCK, PAR VALUE $0.001 | |
Fortress Biotech Inc | Malcolm Hoenlein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2023 | 50,000 | 535,636 (0%) | 0% | 0 | COMMON STOCK, PAR VALUE $0.001 | |
Fortress Biotech Inc | Malcolm Hoenlein | Director | Purchase of securities on an exchange or from another person at price $ 18.00 per share. | 26 Aug 2020 | 16,667 | 16,667 | - | 18 | 300,006 | SERIES A CUMULATIVE PERPETUAL PREFERRED STOCK |